Kevin P. Madauss

Boston University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index2.4kcitations76works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(21), Microtubule and mitosis dynamics(20), Biotechnology and Related Fields(10), Genetics, Bioinformatics, and Biomedical Research(8), Hormonal Regulation and Hypertension(7)

Publications76 total

Influence of SLAM Family Receptors in the NK‐Cell‐Mediated Surveillance of Lymphoblastic Acute Leukemia
European Journal of Immunology·2025
Amyloids in bladder cancer hijack cancer-related proteins and are positive correlated to tumor stage
Scientific Reports·2025· 1 citedOpen Access
Correction: Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells
eLife·2023· 1 citedOpen Access
Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells
eLife·2023· 9 citedOpen Access
Figure S5 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S3 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Supplementary Methods from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S2 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Supplementary Methods from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S1 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S2 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S6 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S6 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Data from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S4 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S3 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S1 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S4 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S5 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Table S1 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Shawn P. Williams(22), Israel Gloger(12), Eugene L. Stewart(11), María Florencia Pansa(11), José Luís Bocco(11), Vanesa Gottifredi(11), Gastón Soria(11), Sofía Carbajosa(10), Natalia S. Paviolo(10), Gerard Drewes(10), Aaron B. Miller(8), Laura Guantay(7), Randy K. Bledsoe(6), G. Bruce Wisely(6), Scott K. Thompson(6), David N. Deaton(6), Iris Alejandra García(6), Ana C. Racca(6), Virginia Angiolini(6), Florencia Villafañez(6)